Lin Peng, Wang Wei, Cai Wen-juan, Han Chun-rong, Sun Yan, Li Man, Sun Bao-cun
Department of Otorhinolaryngology Head and Neck Surgery, Tianjin First Central Hospital, Tianjin 300192, China.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009 Jun;44(6):480-5.
Analyze the relationship between the expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and epidermal growth factor receptor (EGFR) and CD105 micro vessel density (MVD) and their value in evaluating biologic behavior and prognosis in laryngeal cancer.
Ninety-one cases of laryngeal cancer were analyzed about their clinical and pathology data. In tumor tissue the expression of HIF-1alpha and EGFR was detected by immunohistochemistry and MVD was marked by CD105.
The expression of HIF-1alpha was correlated with size, TNM stage, T stage, lymph node metastasis and histological grade (all P<0.05). The expression of EGFR was correlated with TNM stage, lymph node metastasis, histological grade and relapse (all P<0.05). MVD was correlated with type, TNM stage, T stage, lymph node metastasis, metastasis and histological grade (all P<0.05). The expression of HIF-1alpha and EGFR was correlated with MVD (F value was 7.644 and 5.197 respectively, P value was 0.001 and 0.025 respectively). The correlation between the expression of HIF-1alpha and EGFR was significant statistically (r= 0.238, P=0.007). The survival rate of patients of 3 years and 5 years were 56.1% and 44.2% respectively. Survival analysis by Log Rank showed that prognosis of laryngeal cancer patients was correlated with type, TNM stage and the expression of both HIF-1alpha and EGFR. While Cox multiple factors analysis demonstrated that TNM stage and expression of EGFR were independent prognostic factor of laryngeal cancer (P value was 0.049 and 0.041 respectively, RR was 1.300 and 2.417 respectively).
HIF-1alpha and EGFR are key molecular event during development and progression of laryngeal cancer, which act in regulating tumor angiogenesis as well, and show intimate relationship with biological behavior and prognosis of laryngeal cancer.
分析缺氧诱导因子-1α(HIF-1α)、表皮生长因子受体(EGFR)的表达及CD105微血管密度(MVD)之间的关系,以及它们在评估喉癌生物学行为和预后中的价值。
分析91例喉癌患者的临床及病理资料。采用免疫组织化学法检测肿瘤组织中HIF-1α和EGFR的表达,用CD105标记MVD。
HIF-1α的表达与肿瘤大小、TNM分期、T分期、淋巴结转移及组织学分级均相关(均P<0.05)。EGFR的表达与TNM分期、淋巴结转移、组织学分级及复发均相关(均P<0.05)。MVD与肿瘤类型、TNM分期、T分期、淋巴结转移、远处转移及组织学分级均相关(均P<0.05)。HIF-1α和EGFR的表达与MVD相关(F值分别为7.644和5.197,P值分别为0.001和0.025)。HIF-1α与EGFR表达之间的相关性具有统计学意义(r = 0.238,P = 0.007)。3年和5年生存率分别为56.1%和44.2%。Log Rank生存分析显示,喉癌患者的预后与肿瘤类型、TNM分期以及HIF-1α和EGFR的表达均相关。而Cox多因素分析表明,TNM分期和EGFR表达是喉癌的独立预后因素(P值分别为0.049和0.041,RR分别为1.300和2.417)。
HIF-1α和EGFR是喉癌发生发展过程中的关键分子事件,它们也参与调节肿瘤血管生成,并且与喉癌的生物学行为和预后密切相关。